Effector Therapeutics Inc (EFTR)
$0.04
Performance
- $0.04$0.05$0.04
0.0%
Downside
Day's Volatility :11.11%
Upside
11.11%
- $0.04$22.50$0.04
0.0%
Downside
52 Weeks Volatility :99.82%
Upside
99.82%
Returns
| Period | Effector Therapeutics Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -96.92% | 0.0% |
6 Months | -99.7% | 0.0% |
1 Year | -99.75% | 0.0% |
3 Years | -99.99% | -21.4% |
Highlights
Market Capitalization | 188.2K |
Book Value | $0.21 |
Earnings Per Share (EPS) | -12.57 |
Wall Street Target Price | 10.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -83.33% |
Return On Equity TTM | -946.56% |
Revenue TTM | 675.0K |
Revenue Per Share TTM | 0.35 |
Quarterly Revenue Growth YOY | 117.0% |
Gross Profit TTM | -19.8M |
EBITDA | -32.6M |
Diluted Eps TTM | -12.57 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -6.17 |
EPS Estimate Next Year | -2.25 |
EPS Estimate Current Quarter | -2.16 |
EPS Estimate Next Quarter | -1.67 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 27400.0%
Technicals Summary
Sell
Neutral
Buy
Effector Therapeutics Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Effector Therapeutics Inc | -11.11% | -99.7% | -99.75% | -99.99% | -99.99% |
 Regeneron Pharmaceuticals, Inc. | 1.63% | 16.79% | 36.21% | 69.09% | 305.56% |
 Novo Nordisk A/s | 2.32% | -1.45% | 34.23% | 160.46% | 417.73% |
 Alnylam Pharmaceuticals, Inc. | -8.76% | 64.72% | 22.51% | 32.46% | 198.44% |
 Vertex Pharmaceuticals Incorporated | 0.44% | 13.16% | 36.42% | 144.55% | 167.72% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Effector Therapeutics Inc | NA | NA | NA | -6.17 | -9.47 | -0.83 | NA | 0.21 |
Regeneron Pharmaceuticals, Inc. | 29.93 | 29.93 | 1.54 | 45.05 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 44.01 | 44.01 | 1.98 | 3.44 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.55 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.57 | 0.32 | -0.03 | 0.13 | NA | 57.26 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Effector Therapeutics Inc | Buy | $1.4M | -99.99% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $124.7B | 305.56% | 29.93 | 32.04% |
Novo Nordisk A/s | Buy | $585.3B | 417.73% | 44.01 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $32.3B | 198.44% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $120.9B | 167.72% | 32.84 | -4.74% |
Insights on Effector Therapeutics Inc.
Decreasing Revenue
Revenue is down for the last 4 quarters, 2.01M → 162.0K (in $), with an average decrease of 51.7% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -9.12M → -8.83M (in $), with an average increase of 3.3% per quarter
Vs VRTX
In the last 1 year, Vertex Pharmaceuticals Incorporated has given 36.4% return, outperforming this stock by 136.2%
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 144.6% return, outperforming this stock by 244.6%
Institutional Holdings
Armistice Capital, LLC
4.74%The Carlyle Group Inc
4.10%StemPoint Capital LP
2.82%Sectoral Asset Management Inc
2.03%Vanguard Group Inc
1.97%Ensign Peak Advisors Inc
0.70%
Company Information
effector therapeutics is a biotechnology company located in 11180 roselle street, san diego, ca, united states.
Organization | Effector Therapeutics Inc |
Employees | 14 |
CEO | Dr. Stephen T. Worland Ph.D. |
Industry | Miscellaneous |
Discover More
A Spac I Acquisition Corp
$0.04
+0.0%
Keyarch Acquisition Corp
$0.04
+0.0%
Connexa Sports Technologies Inc
$0.04
+0.0%
Us Value Etf
$0.04
+0.0%
First Wave Biopharma Inc
$0.04
+0.0%
Global X Msci Next Emerging
$0.04
+0.0%
Fat Projects Acquisition Corp
$0.04
+0.0%
Capital Link Global Fintech
$0.04
+0.0%
Applied Uv Inc
$0.04
+0.0%